Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Indianapolis, Indiana 46202


Purpose:

The purpose of this trial is to show adequate assay performance on clinical samples tested in real time at the clinical site.


Study summary:

This study will determine the sensitivity, specificity, negative predictive value, and positive predictive value of the GeneSearch™ BLN Assay in patient samples by comparing its performance to that of the current methods -- permanent section Hematoxylin and Eosin (H&E) staining with IHC. Additional marker testing using probes associated with nodal metastases may be used in the assay performance calculations. The observed performance measures will be compared to those obtained in the larger U.S. registration trial to show that there are no differences in the assay's performance.


Criteria:

Inclusion Criteria: - Previous diagnosis of carcinoma of the breast - Patient scheduled for sentinel lymph node dissection as per standard of care at the clinical site - 18 years or older - Female or male, and - Able and willing to give consent to participate in the study Exclusion Criteria: - Patients taking part in other research studies that would interfere with their full participation in this study


NCT ID:

NCT00551278


Primary Contact:

Principal Investigator
Robert J. Goulet, MD
Indiana University Cancer Pavilion


Backup Contact:

N/A


Location Contact:

Indianapolis, Indiana 46202
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.